Cite
APA Citation
Fernandez, E., Vernet, R., Charrier, E., Joerger, M., de Belkouch, M., Urwyler, M., von Rohr, O., Rubin, O., Villard, J., Ancrenaz, V., Grandjean, N., Lavallière, E., Lafferma, E., Grogg, J., & Mach, N. (n.d.). p-190 Personalized Immunotherapy with Cell-Encapsulation Technology for 2nd line R/M HNSCC: Safety and Early Efficacy Data from all HNSCC patients treated with MVX-ONCO-1 in two clinical trials. Oral oncology, 118, 6–. http://access.bl.uk/ark:/81055/vdc_100133913362.0x000034